BA
SRRA

BlackRock Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

BlackRock Advisors’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,038
Closed -$1.67M – 3850
2015
Q3 		$1.67M Buy
+2,038
New +$2.3M ﹤0.01% 1417

Other funds holding SRRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock Advisors's SRRA Position: Q4 2015 in Review

BlackRock Advisors sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q4 2015, closing a stake of 2,038 shares — an estimated $1.67M sold.

BlackRock Advisors first reported a position in SRRA in Q3 2015 and held it in 1 quarter. The position peaked at $1.67M in Q3 2015. 47 funds tracked by Wall St. Rank hold SRRA as of Q4 2015.

  • BlackRock Advisors reported no remaining Sierra Oncology, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • BlackRock Advisors sold 2,038 Sierra Oncology, Inc. Common Stock shares in Q4 2015, an estimated $1.67M.
  • BlackRock Advisors first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 1 quarter.
  • BlackRock Advisors's Sierra Oncology, Inc. Common Stock position peaked at $1.67M in Q3 2015.
  • 47 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q4 2015.

Based on BlackRock Advisors's 13F filing for Q4 2015, filed 11 Feb 2016.